These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16886139)

  • 41. Prior authorization made easier.
    Terry K
    Med Econ; 2007 Oct; 84(20):34, 38, 40. PubMed ID: 18075056
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of privatization of the drug distribution system on drug prices in Malaysia.
    Babar ZD; Izham MI
    Public Health; 2009 Aug; 123(8):523-33. PubMed ID: 19665741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generic substitution--issues relating to the Australian experience.
    McGavock H
    Pharmacoepidemiol Drug Saf; 2001; 10(6):555-6. PubMed ID: 11828839
    [No Abstract]   [Full Text] [Related]  

  • 44. Health care expenditures of living with a disability: total expenditures, out-of-pocket expenses, and burden, 1996 to 2004.
    Mitra S; Findley PA; Sambamoorthi U
    Arch Phys Med Rehabil; 2009 Sep; 90(9):1532-40. PubMed ID: 19735781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications.
    Farley JF; Cline RR; Schommer JC; Hadsall RS; Nyman JA
    Clin Ther; 2008 Aug; 30(8):1524-39; discussion 1506-7. PubMed ID: 18803994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Value-Based Physician Payment in Oncology: Public and Private Insurer Initiatives.
    Robinson JC
    Milbank Q; 2017 Mar; 95(1):184-203. PubMed ID: 28266072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hypertension--a social problem and the tasks of health services].
    Chodakowska J
    Kardiol Pol; 1978; 21(3):173-6. PubMed ID: 99594
    [No Abstract]   [Full Text] [Related]  

  • 48. Use of Skin Cancer Procedures, Medicare Reimbursement, and Overall Expenditures, 2012-2017.
    Puri P; Baliga S; Pittelkow MR; Bhullar PK; Mangold AR
    JAMA Netw Open; 2020 Nov; 3(11):e2025139. PubMed ID: 33170260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Democrats prioritize pricing, generics and drug safety.
    Fox JL
    Nat Biotechnol; 2007 Feb; 25(2):150-1. PubMed ID: 17287735
    [No Abstract]   [Full Text] [Related]  

  • 50. [The patient is without rights if the drug company is not included in the pharmaceutical insurance].
    Eklund J
    Lakartidningen; 2013 Nov 6-12; 110(45):2005. PubMed ID: 24364190
    [No Abstract]   [Full Text] [Related]  

  • 51. Could a Wal-Mart PBM succeed?
    Carroll J
    Manag Care; 2008 Apr; 17(4):36-8. PubMed ID: 18464572
    [No Abstract]   [Full Text] [Related]  

  • 52. Are Recently Evaluated Drugs More Likely to Receive Positive Reimbursement Recommendations in South Korea? 11-year Experience of the South Korean Positive List System.
    Gong JR; Lee D; Lim KM; Bae S
    Clin Ther; 2020 Jul; 42(7):1222-1233. PubMed ID: 32487429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reimbursement risks with radiologist extenders: there is no free lunch!
    Thorwarth WT
    J Am Coll Radiol; 2004 Jun; 1(6):405-9. PubMed ID: 17411617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Purchasing & supply. Kick the drug habit.
    Mathieson S
    Health Serv J; 2003 Nov; 113(5880):suppl 7. PubMed ID: 14628632
    [No Abstract]   [Full Text] [Related]  

  • 55. [Problem-free reimbursement changes for COPD].
    Sørensen BN
    Tidsskr Nor Laegeforen; 2007 Mar; 127(5):623. PubMed ID: 17332826
    [No Abstract]   [Full Text] [Related]  

  • 56. Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance.
    Godman B; Wettermark B; Hoffmann M; Andersson K; Haycox A; Gustafsson LL
    Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):65-83. PubMed ID: 19371180
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brand substitution or multiple switches per patient? An analysis of pharmaceutical brand substitution in Australia.
    Kalisch LM; Roughead EE; Gilbert AL
    Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):620-5. PubMed ID: 18324613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Learning from health system reforms: lessons from Burkina Faso.
    Haddad S; Nougtara A; Fournier P
    Trop Med Int Health; 2006 Dec; 11(12):1889-97. PubMed ID: 17176354
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Agreement between pharmacists for problem identification: an initial quality measurement of cognitive services.
    LaFleur J; Larson BS; Gunning KM; Stoddard GJ; Madden C; Oderda L; Steinvoort C; Oderda GM
    Ann Pharmacother; 2009 Jul; 43(7):1173-80. PubMed ID: 19584393
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Health insurance discount contracts: problems and risks for the general practitioner in the medical care of patients with chronic illness].
    Leutgeb R; Mahler C; Laux G; Weschnetz A; Szecsenyi J
    Dtsch Med Wochenschr; 2009 Jan; 134(5):181-6. PubMed ID: 19180404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.